Momo Hirata

Identification of Biomarkers for Non–small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor

Keisuke Watanabe, Y. Hara, T. Kaneko, 2020, AntiCancer Research.

T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer

N. Horita, Keisuke Watanabe, Y. Hara, 2021, Thoracic cancer.

Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease

N. Horita, Keisuke Watanabe, N. Kobayashi, 2023, Scientific reports.

High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse

N. Horita, Keisuke Watanabe, N. Kobayashi, 2024, PloS one.